Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Falasca

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
Cells|December 17, 2024
Comprehensive Assessment of Cannabidiol and HU308 in Acute and Chronic Colitis Models: Efficacy, Safety, and Mechanistic InnovationsDinesh Thapa, Mohan Patil, Leon N Warne, et al.
Journal of Cell Science|March 29, 2012
A novel regulatory mechanism links PLCγ1 to PDK1Claudio Raimondi, Anissa Chikh, Ann P Wheeler, et al.
The EMBO Journal|August 13, 2003
Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activationTania Maffucci, Anna Brancaccio, Enza Piccolo, et al.
Cancers|October 17, 2020
Cancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast CancerYeuan Ting Lee, Yi Jer Tan, Marco Falasca, et al.
Cancers|October 25, 2017
The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine ResistanceOmar Elaskalani, Marco Falasca, Niamh Moran, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 28, 2011
Targeting phosphoinositide 3-kinase pathways in pancreatic cancer--from molecular signalling to clinical trialsMarco Falasca, Federico Selvaggi, Richard Buus, et al.
Cancer Biology & Therapy|February 14, 2014
Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathwayCharlotte E Edling, Federico Selvaggi, Ragheda Ghonaim, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011Dinesh Thapa, Mohan Patil, Leon N Warne, et al.
International Journal of Molecular Sciences|February 24, 2024
Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer ModelsRanjith Palanisamy, Nimnaka Indrajith Kahingalage, David Archibald, et al.
Signal Transduction and Targeted Therapy|May 6, 2025
Oncogenic proteome of pancreatic cancer extracellular vesicles: sodium/myo-inositol cotransporter as a potential markerArunima Panda, Krish Ragunath, Marina Pajic, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Cells|December 17, 2024
Comprehensive Assessment of Cannabidiol and HU308 in Acute and Chronic Colitis Models: Efficacy, Safety, and Mechanistic InnovationsDinesh Thapa, Mohan Patil, Leon N Warne, et al.
Journal of Cell Science|March 29, 2012
A novel regulatory mechanism links PLCγ1 to PDK1Claudio Raimondi, Anissa Chikh, Ann P Wheeler, et al.
The EMBO Journal|August 13, 2003
Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activationTania Maffucci, Anna Brancaccio, Enza Piccolo, et al.
Cancers|October 17, 2020
Cancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast CancerYeuan Ting Lee, Yi Jer Tan, Marco Falasca, et al.
Cancers|October 25, 2017
The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine ResistanceOmar Elaskalani, Marco Falasca, Niamh Moran, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 28, 2011
Targeting phosphoinositide 3-kinase pathways in pancreatic cancer--from molecular signalling to clinical trialsMarco Falasca, Federico Selvaggi, Richard Buus, et al.
Cancer Biology & Therapy|February 14, 2014
Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathwayCharlotte E Edling, Federico Selvaggi, Ragheda Ghonaim, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2025
Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011Dinesh Thapa, Mohan Patil, Leon N Warne, et al.
International Journal of Molecular Sciences|February 24, 2024
Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer ModelsRanjith Palanisamy, Nimnaka Indrajith Kahingalage, David Archibald, et al.
Signal Transduction and Targeted Therapy|May 6, 2025
Oncogenic proteome of pancreatic cancer extracellular vesicles: sodium/myo-inositol cotransporter as a potential markerArunima Panda, Krish Ragunath, Marina Pajic, et al.
Pageof 15